In the preceding three months, 12 analysts have released ratings for BioNTech (NASDAQ:BNTX), presenting a wide array of perspectives from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 9 | 1 | 2 | 0 | 0 |
Last 30D | 1 | 0 | 0 | 0 | 0 |
1M Ago | 5 | 0 | 0 | 0 | 0 |
2M Ago | 2 | 1 | 2 | 0 | 0 |
3M Ago | 1 | 0 | 0 | 0 | 0 |
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $110.92, along with a high estimate of $122.00 and a low estimate of $98.00. This current average has decreased by 0.61% from the previous average price target of $111.60.
Breaking Down Analyst Ratings: A Detailed Examination
A clear picture of BioNTech's perception among financial experts...
Login or create a forever free account to read this news
Sign up/Log in